Polyethylene Glycol Loxenatide Injection.

Polyethylene glycol loxenatide injection is a blood sugar control drug for diabetics. In clinical practice, this product is used alone or in combination with metformin in combination with diet control and exercise to improve blood sugar control in adult patients with type 2 diabetes.
The main ingredient of polyethylene glycol loxenatide injection is polyethylene glycol loxenatide, which can stimulate the intestine to secrete incretin. After entering the blood, it acts on pancreatic beta cells, stimulates the pancreas to secrete insulin, and inhibits the secretion of glucagon, which plays a role in controlling blood sugar levels and lowering blood sugar.